Inhaled Tobramycin in the Treatment of Severe Nosocomial Pneumonias

Inhaled Tobramycin in the Treatment of Severe Nosocomial Pneumonias

Objective: to evaluate the efficiency of using inhaled tobramycin in addition to systemic antibacterial therapy in the treatment of severe nosocomial pneumonias (NP) in critically ill patients. NP remains one of the most urgent problems in resuscitative units. Traditional intravenous injection of br...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Moroz, A. N. Kuzovlev, S. G. Polovnikov, V. V. Stets, V. V. Varvarin
Format:	Article
Language:	English
Published:	Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2012-04-01
Series:	Общая реаниматология
Online Access:	https://www.reanimatology.com/rmt/article/view/224
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhaled Antibiotics in the Treatment of Nosocomial Pneumonia
by: A. N. Kuzovlev, et al.
Published: (2013-12-01)

SAFETY-MODE RESPIRATORY SUPPORT IN NOSOCOMIAL PNEUMONIA
by: V. V. Moroz, et al.
Published: (2015-05-01)

Dynamics of Inhaled Tobramycin Concentration in Blood and Bronchoalveolar Lavage Fluid during Nosocomial Pneumonia (Preliminary Report)
by: A. N. Kuzovlev, et al.
Published: (2018-10-01)

Diagnosis of Acute Respiratory Distress Syndrome in Nosocomial Pneumonia
by: A. N. Kuzovlev, et al.
Published: (2009-12-01)

Comparison of Antibacterial Activities of Tobramycin Inhalation Solutions
by: V. V. Pisarev
Published: (2020-05-01)

Experience of the use of tobramycin for inhalation in children with cystic fibrosis
by: A. V. Orlov, et al.
Published: (2012-02-01)

Assessment of Aerosolized Colistin Efficacy for Nosocomial Pneumonia
by: A. N. Kuzovlev, et al.
Published: (2017-12-01)

Clinical and Morphological Features of Nosocomial Pneumonia in Patients with Peritonitis
by: T. V. Smelaya, et al.
Published: (2008-06-01)

Role of Early Immune Replacement Therapy in Reducing the Rate of Nosocomial Pneumonia in Severe Polytrauma
by: A. K. Shabanov, et al.
Published: (2014-12-01)

Search for Common Molecular Genetic Markers of Nosocomial Pneumonia and Acute Respiratory Distress Syndrome
by: T. V. Smelaya, et al.
Published: (2015-07-01)

Clara Cell Protein (Club Cell Protein) is a New Diagnostic Molecular Candidate Biomarker in Nosocomial Pneumonia
by: V. V. Moroz, et al.
Published: (2014-12-01)

Community-Acquired and Nosocomial Pneumonia: Clinical and Morphological Features
by: A. M. Golubev, et al.
Published: (2010-06-01)

Inhalation surfactant therapy in the integrated treatment of severe COVID-19 pneumonia
by: A. E. Bautin, et al.
Published: (2020-10-01)

Time Course of Changes in the Level of Procalcitonin in the Development of Nosocomial Pneumonia in Victims with Severe Concomitant Injury in an Intensive Care Unit
by: A. K. Shabanov, et al.
Published: (2013-10-01)

Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria
by: Guergana Petrova, et al.
Published: (2016-11-01)

Inhaled Polymyxin in Treatment of Elderly Patients with Severe Community-Acquired Klebsiella pneumoniae-Induced Pneumonia
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Antibacterial Therapy for Nosocomial Pneumonias Caused by Multidrug-Resistant Microorganisms in Critical 1ll Patients
by: V. V. Moroz, et al.
Published: (2007-06-01)

Features of nosocomial Klebsiella pneumoniae population
by: S. A. Kuzmenko, et al.
Published: (2019-06-01)

EFFICIENCY OF TRANSPULMONARY THERMODILUTION IN THE OPTIMIZATION OF INTENSIVE TREATMENT IN PATIENTS WITH SEVERE NOSOCOMIAL PNEUMONIA
by: S. N. Avdeykin, et al.
Published: (2015-05-01)

Prevention of Nosocomial Respiratory Infections
by: N. A. Karpun, et al.
Published: (2007-06-01)

Acute Lung Injury In Pneumonias
by: V. V Moroz, et al.
Published: (2008-06-01)

PREVENTION OF NOSOCOMIAL PNEUMONIAS IN A SURGICAL INTENSIVE CARE UNIT
by: O. A. Orlova, et al.
Published: (2016-03-01)

NEW STEP IN THE LIFE QUALITY IMPROVEMENT OF PATIENTS WITH MUCOVISCIDOSIS: TOBRAMYCIN FOR ANAPNOTHERAPY
by: V. V. Chernikov, et al.
Published: (2012-10-01)

Redefining ventilator-associated pneumonia treatment: a novel economic analysis of tobramycin and colistin’s cost-effectiveness
by: Jefferson Antonio Buendía, et al.
Published: (2025-07-01)

Treatment Guidelines for Nosocomial Pneumonia: Agreeing to Disagree
by: R Bruce Light
Published: (1993-01-01)

Inhaled Antibiotics in Reanimatology: Problem State and Development Prospects (Review)
by: A. N. Kuzovlev, et al.
Published: (2018-01-01)

Synthesis and Antibacterial Activity of New 6″-Modified Tobramycin Derivatives
by: Kseniya S. Shapovalova, et al.
Published: (2024-12-01)

Current project of management guidelines of the patients with nosocomial pneumonia in adults
by: Maria A. Karnaushkina, et al.
Published: (2017-07-01)

CURRENT STATE AND PERSPECTIVE OF DIAGNOSTICS OF NOSOCOMIAL PNEUMONIA IN THOSE INJURED WITH MULTIPLE TRAUMA
by: A. V. Prokhorov, et al.
Published: (2018-01-01)

DIAGNOSTICS OF NOSOCOMIAL PNEUMONIA IN THOSE WITH MULTIPLE TRAUMAS (BASING ON DATA OF FOREIGN PUBLICATIONS)
by: A. V. Prokhorov, et al.
Published: (2018-01-01)

Nosocomial Infection in Patients with Severe and Critical COVID-19
by: M. V. Bychinin, et al.
Published: (2022-02-01)

A Clinical Case of Effective Treatment of Pneumonia Caused by Polyresistant Strains with the Use of Inhalation Colistimethate Sodium
by: M. A. Balalaeva, et al.
Published: (2022-12-01)

Diversification of <i>Pseudomonas aeruginosa</i> After Inhaled Tobramycin Therapy of Cystic Fibrosis Patients: Genotypic and Phenotypic Characteristics of Paired Pre- and Post-Treatment Isolates
by: Dayana Borisova, et al.
Published: (2025-03-01)

The Effect of Nosocomial Infection on the Severity and Outcome of the Disease in Patients with Severe and Extremely Severe COVID-19
by: L. M. Kalmanson, et al.
Published: (2022-01-01)

Nosocomial <i>Klebsiella pneumoniae</i> infection in a cardiac surgery hospital: clinical and microbiological features
by: M. V. Kuznetsova, et al.
Published: (2024-12-01)

ANALYSIS OF FUNCTIONAL ELECTRICAL ANNEX DIAGRAMS OF WIND ENERGY CONVERSION SYTEMS
by: S. G. Polovnikov, et al.
Published: (2014-04-01)

PNEUMONIA IN PATIENTS WITH BRONCHO-OBSTRUCTIVE DISEASES TREATED WITH INHALED GLUCOCORTICOSTEROIDS
by: E. A. Kulagin, et al.
Published: (2017-06-01)

Recurrent diffuse panbronchiolitis after lung transplantation: Off-label use of inhaled tobramycin for Pseudomonas aeruginosa control in a transplant recipient
by: Shin Tanaka, et al.
Published: (2025-07-01)

Neuroprotective Effects of Inhaled Xenon for Sedation Compared With Propofol Intravenous Sedation in Severe Ischemic Stroke
by: O. A. Grebenchikov, et al.
Published: (2023-02-01)

Neuroprotective Properties of Inhaled Argon-Oxygen Mixture after Photochemically Induced Ischemic Stroke
by: Ekaterina A. Boeva, et al.
Published: (2023-09-01)